Can a smartphone app help tame the 'Three Highs'? new trial aims to find out

NCT ID NCT07588256

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large trial in New Taipei City will test whether a mobile digital health platform with interactive modules helps people better control high blood pressure, high blood sugar, and high cholesterol. It will also compare taking blood pressure medication at night versus in the morning to see which works better for morning blood pressure. Over 4,000 participants will be enrolled, and the study will track outcomes like blood pressure targets, cholesterol levels, and kidney function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Interactive digital modules and antihypertensive medication management (nocturnal vs. morning dosing)
What this could lead to
If successful, this could show that a digital health platform helps more people control their blood pressure, blood sugar, and cholesterol, and that taking blood pressure meds at night may be better for morning control.
What could go wrong
This is a large but early-stage trial without a drug or device; results depend on patient engagement with the digital platform. The medication timing comparison may not show a clear benefit, and real-world adherence could be lower than in the study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • United safety medical group(USMG)

    RECRUITING

    New Taipei City, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.